Skip to main content
Equibles

Invesco Ltd.

Position in DSGN — Design Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$310,076
-$1,199,951 QoQ
Shares Held
21,429
-84.9% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 136 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 0% Shared 96% None 4%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. DSGN ranks #219 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in DSGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $310,076 21,429
2026-03-31 $1,510,027 141,920
2025-12-31 $2,868,000 305,757
2025-09-30 $109,854 14,589
2025-06-30 $48,405 14,364
2025-03-31 $43,735 11,331
2024-12-31 $71,465 11,583
2024-03-31 $42,210 10,474
2023-12-31 $28,982 10,937
2022-09-30 $168,169 10,058
2022-06-30 $141,918 10,137
2021-12-31 $206,007 9,622